Member Info for Heimdal

Alquemie / Italian, thank you for sharing! Heimdal

Indeed, disappointing finish @ 18.7c and the constant selling pressure all day.

Bignose, do you think we will get an update on FDA progress this year?

Interesting times bignose. SP slowly drifting below 20c now with 55.5m shares traded during the 1st hour.
Hopefully DLI will add significant value over time. You mentioned RPG will have access to 3.79mill USD
from DLI, is that really correct? If so then short term funding will not be an issue.

My main concern is the overheating US market. How long will this last with average S&P 500 P/E of >30?
% change in operating EPS from last year is -23%, yet average P/E is up by 47.4%.

https://www1.hkexnews.hk/listedco/listconews/sehk/2020/1214/2020121400274.pdf

I am very pleased with the TAIWAN approval - well done!

".. the Directors are pleased to inform shareholders that Orient EuroPharma Co., Ltd. (“Orient EuroPharma”), the Group’s
commercial strategic partner for Taiwan, Hong Kong Special Administrative Region (“Hong Kong”), Macau Special Administrative Region (“Macau”) and certain other countries in South East Asia, has informed the Group on 11 December 2020 that it has received marketing authorisation approval for Taiwan from the Taiwan Food and Drug Administration (“TFDA”). This is the final regulatory approval process required for the marketing, distribution and sale of Fortacin
in Taiwan.

The regulatory approval from the TFDA has triggered a payment of US$300,000 (or approximately HK$2.34 million) to the Group. The Group understands that Orient EuroPharma expects to launch Fortacin in Taiwan, Hong Kong and Macau in 2021."

Heimdal

"Following the transaction, DLI will become a wholly owned subsidiary of the Company. The
Board believes that the acquisition of DLI will add a high-quality growth asset to the Company,
which will serve as a key platform for its expansion into the health and wellness sector, namely
the emerging field of longevity (m e d i c i n e)." Looking forward to hear more on this. Heimdal

More news from the DLI front:

https://www.news-medical.net/news/20201209/Study-describes-novel-aging-clock-trained-to-predict-human-age.aspx

Just joking bignose, I understand you are a significant LT holder.

Somewhat surprised with only 3m votes cast at the EGM. For as moment I though maybe it was bignose voting against
with his mighty holding ;-)

A separate announcement will be issued by the company upon closing of the DLI acquisition, and that might well have some impact on the sp. For now we have support at the 18c level which is positive.

The share price has consolidated at the 17-18c level and last night Hong Kong Bulls issued a BUY recommendation @ 18c.

What will drive the sp upward in the short-medium term? Probably a combination of 1) EGM news tomorrow, 2) FDA news ?later this month, 3) OTC in the EU 4) Taiwan approval in January and 5) China +/- HK-Macao news in Q1. There could well be other news out of left field which might spark a long overdue recovery rally. We should also benefit from the Juvenescence IPO due next year.

We are running low on cash so the $800,000 Christmas gift from Wanbang will be appreciated. EuroPharma will also contribute with $300,000 in January (from Taiwan approval) and Wanbang will pay $3,200,000 in Q1. That is much needed cash.

The ATO issue has been outstanding for years and can probably be pushed forward again. Our current holding in VXR is valued at AU$3.5 and expected to increase next year and might be sufficient to settle the ATO debt at a later date.

Hopefully DLI will add value for Regent share holders. It is a benefit that DLI is HK based. Zhavoronkov will be a major holder from tomorrow 11 am and should strengthen our management team. It seems like a dynamic group and I look forward to follow their progress in a new field (for me).

Looking at the bullish chart and expected news flow I think we are getting set for another leg up.

Please note: current Market Cap is only $42m, so a lot of upside here (even with DLI dilution). Let's see how the market react tomorrow/Thursday to the EGM news.

Thanks for sharing.

Looks like we are drifting towards support at 14-15c?

Same pattern this morning bignose, just two buys for 30k shares out of a volume of 737k.

Only 2M shares traded today with just 4 buys for a total of 80k shares. This "wave" did not last long..

Young.AI app is down! I received this e.mail from DLI: "Hi there! It is Anthony, Young.ai Product Manager. I would like to inform you about two important things: the access changes and our update schedule. Our web application has been moved to a new address. young.ai ? app.young.ai No need to worry. All data is saved. The functional is the same and will be better with our new release very soon. Due to some upgrade technical reasons, our mobile application is not available now, and users might not be able to log in. But it will not last long, and you can continue using our app with the 1.03 version. It is coming to Apple Store very soon, don't miss it." This is clearly not a good start. Looks like DLI rushed the app through and now it is down.

Lock up is 6 months for DLI majority holders and 12 months for minority holders.

I just wonder if DLI can actually generate any meaningful revenues for Regent Pacific on the short to medium track. Not very impressed by Polina Mamoshina on the recent Master Investor webinar. I think she mentioned something along the lines of the biggest achievement for DLI this year was the Regent Pacific acquisition without even mentioning our company name. It appears "Reason" was also critical of the usefulness of the ageing clocks, that is a worry. The flagged Juvenescence IPO might well spark some investor interest in HK but will DLI be able to generate any tangible income? Another growing concern is lack of funding to support the ongoing FDA work, support DLI research, keep the lights on in the HK office, pay salaries, the outstanding ATO tax bill etc. I guess we will need to raise min. $10m post DLI acquisition? I had a look at the interim report again, we must be running on fumes by now with current burn rate?

BEARISH ENGULFING. HK Bulls now show a sell level of 18.4c after the new bearish engulfing chart pattern.
We are now trading below the upper bollinger band. Given the constant selling pressure and fast stochastic change point
detection I expect we might be closing the gap shortly before we go higher. However, one growing concern for me is funding. We must be running on fumes now and I am not sure how we can pay the ATO bill due next month, fund FDA work as well as keep DL afloat without a capital raising of $10m or so.

Bignose, 3,500,000 was left on the BUY side at and above 18c at close of trading at 16:08 (incl +2,000,000 at 18.3c) - unfilled BUY orders ok.

Holding up well again today with 3,500,000 on BUY side at 18c and above at close (incl +2,000,000 at 18.3c).
KGI Asia frequently noted at front end of BUY side today. Let the good times roll!

Exactly. Holding up very well indeed. UBS very active at the front end of the BUY side today. Yesterday it was Deutsche.